Leslie Holsinger

(DR. Leslie Holsinger Ph.D.)

Currently holds a position at Cortexyme Inc

Positions

Position Company Period
Executive Vice President - Preclinical Development Cortexyme Inc Jan. 1, 2018 -
Vice President - Preclinical Dev. Cortexyme Inc April 1, 2016 - Dec. 1, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-15 2020-12-14
US Cortexyme Inc (CRTX)
PS Planned sale
900 -20.5%
32.59
USD 29,331 		900 -20.5% 32.59 USD 29,331
2020-12-15 2020-12-14
US Cortexyme Inc (CRTX)
PS Planned sale
400 -8.3%
32.59
USD 13,034 		400 -8.3% 32.59 USD 13,034
2020-12-15 2020-12-14
US Cortexyme Inc (CRTX)
PS Planned sale
9,525 -84.1%
31.79
USD 302,800 		9,525 -84.1% 31.79 USD 302,800
2020-12-15 2020-12-14
US Cortexyme Inc (CRTX)
PS Planned sale
13,200 -48.0%
30.91
USD 408,012 		13,200 -48.0% 30.91 USD 408,012
2020-12-15 2020-12-14
US Cortexyme Inc (CRTX)
PS Planned sale
14,275 -34.2%
30.15
USD 430,391 		14,275 -34.2% 30.15 USD 430,391
2020-12-15 2020-12-14
US Cortexyme Inc (CRTX)
PS Planned sale
1,700 -3.9%
28.80
USD 48,960 		1,700 -3.9% 28.80 USD 48,960
// ... existing code ... // ... rest of the file ...